Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
SLATE-001 by Gritstone Bio for Metastatic Colorectal Cancer: Likelihood of Approval
SLATE-001 is under clinical development by Gritstone Bio and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData,...
SLATE-001 by Gritstone Bio for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
SLATE-001 is under clinical development by Gritstone Bio and currently in Phase II for Pancreatic Ductal Adenocarcinoma. According to GlobalData,...
SLATE-001 by Gritstone Bio for Metastatic Breast Cancer: Likelihood of Approval
SLATE-001 is under clinical development by Gritstone Bio and currently in Phase I for Metastatic Breast Cancer. According to GlobalData,...
SLATE-001 by Gritstone Bio for Metastatic Ovarian Cancer: Likelihood of Approval
SLATE-001 is under clinical development by Gritstone Bio and currently in Phase I for Metastatic Ovarian Cancer. According to GlobalData,...
SLATE-001 by Gritstone Bio for Gastrointestinal Tumor: Likelihood of Approval
SLATE-001 is under clinical development by Gritstone Bio and currently in Phase I for Gastrointestinal Tumor. According to GlobalData, Phase...